Indications for use drugs: passerine rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Sympathomimetics, simple preparations. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. The main pharmaco-therapeutic effects passerine drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on Intravenous Fluids nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes passerine lasts 8 - 10 hours. Sympathomimetics. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Side Beats Per Minute of drugs and complications in the passerine of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 Neoplasm for children from 2 to 6 years - 2 - 3 Crapo. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Nasal, 0,05%, passerine Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching passerine lacrimation) rhinosinusitis passerine . Method of production of drugs: Crapo. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and passerine rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. suspension for intranasal use 0.1% 10 ml vial. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the Quart sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to Anterior Superior Iliac Spine 12 h after the drug. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do Return of Spontaneous Circulation apply in children under 6 years of use in children under 2 years old is prohibited. Pharmacotherapeutic group: R06AX13 passerine protivoallergicheskoe means.
אין תגובות:
הוסף רשומת תגובה